• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性加重期的疼痛与呼吸困难:2019 - 2020年文档审核

Pain and Dyspnea During Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Documentation Audit 2019-2020.

作者信息

Clarke Stephanie Y, Williams Marie T, Johnston Kylie N, Lee Annemarie L

机构信息

Department of Physiotherapy, School of Primary and Allied Health Care, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC 3199, Australia.

Physiotherapy Department, Eastern Health, Melbourne, VIC 3128, Australia.

出版信息

J Clin Med. 2025 Jan 3;14(1):252. doi: 10.3390/jcm14010252.

DOI:10.3390/jcm14010252
PMID:39797334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11720982/
Abstract

Patient-reported outcome measures (PROMs) assess the severity and impact of both pain and dyspnea in those with acute exacerbations of chronic obstructive pulmonary disease (COPD), but their frequency of use in clinical practice is unknown. This study aimed to determine the point prevalence of pain and dyspnea assessment in patients hospitalized with an acute exacerbation of COPD and the measurement tools applied for this purpose in clinical practice. Clinical notes and observation charts of patients admitted with acute exacerbations of COPD to a metropolitan hospital in 2019 and 2020 were retrospectively audited to identify the point prevalence of pain and dyspnea assessment, the PROMs applied, and their associated focal periods. Pain and dyspnea were assessed using a PROM in 99% and 8% of cases of acute exacerbation of COPD, respectively. All PROMs used measured symptom intensity. Focal periods were rarely reported in the assessment of pain; in the dyspnea assessment, timeframes predominantly reflected the impact of exertion. At this single health service site, in people hospitalized with an acute exacerbation of COPD, pain was more frequently assessed using a PROM than dyspnea. Understanding factors influencing clinicians' choice of assessment tools may inform future recommendations for the assessment of these symptoms in people hospitalized with exacerbations of COPD.

摘要

患者报告结局测量指标(PROMs)可评估慢性阻塞性肺疾病(COPD)急性加重患者的疼痛和呼吸困难的严重程度及影响,但在临床实践中的使用频率尚不清楚。本研究旨在确定因COPD急性加重住院患者中疼痛和呼吸困难评估的时点患病率,以及临床实践中用于此目的的测量工具。对2019年和2020年因COPD急性加重入住一家大都市医院的患者的临床记录和观察图表进行回顾性审核,以确定疼痛和呼吸困难评估的时点患病率、所应用的PROMs及其相关的重点时间段。在COPD急性加重病例中,分别有99%和8%的病例使用PROMs评估疼痛和呼吸困难。所有使用的PROMs均测量症状强度。在疼痛评估中很少报告重点时间段;在呼吸困难评估中,时间框架主要反映运动的影响。在这个单一的医疗服务机构,在因COPD急性加重住院的患者中,使用PROMs评估疼痛比评估呼吸困难更频繁。了解影响临床医生选择评估工具的因素可能为未来对COPD急性加重住院患者这些症状评估的建议提供依据。

相似文献

1
Pain and Dyspnea During Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Documentation Audit 2019-2020.慢性阻塞性肺疾病急性加重期的疼痛与呼吸困难:2019 - 2020年文档审核
J Clin Med. 2025 Jan 3;14(1):252. doi: 10.3390/jcm14010252.
2
The prevalence and assessment of pain and dyspnoea in acute exacerbations of COPD: A systematic review.COPD 急性加重期疼痛和呼吸困难的流行情况及评估:系统评价。
Chron Respir Dis. 2022 Jan-Dec;19:14799731221105518. doi: 10.1177/14799731221105518.
3
Risk Factors for Chronic Obstructive Pulmonary Disease Exacerbations among Individuals without a History of Recent Exacerbations: A COPDGene Analysis.无近期加重史个体慢性阻塞性肺疾病加重的危险因素:COPDGene 分析。
Ann Am Thorac Soc. 2024 Mar;21(3):421-427. doi: 10.1513/AnnalsATS.202209-751OC.
4
Exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的急性加重
Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5.
5
The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD.晨症与 COPD 未来加重风险的关系。
Int J Chron Obstruct Pulmon Dis. 2020 Aug 5;15:1899-1907. doi: 10.2147/COPD.S255030. eCollection 2020.
6
A clinical prediction model for hospitalized COPD exacerbations based on "treatable traits".基于“可治疗特征”的住院 COPD 加重临床预测模型。
Int J Chron Obstruct Pulmon Dis. 2019 Mar 27;14:719-728. doi: 10.2147/COPD.S194922. eCollection 2019.
7
Relationship Between Patient-Reported Outcome Measures and the Severity of Chronic Obstructive Pulmonary Disease in the Context of an Innovative Digitally Supported 24-Hour Service: Longitudinal Study.在创新的数字支持24小时服务背景下患者报告结局指标与慢性阻塞性肺疾病严重程度的关系:纵向研究
J Med Internet Res. 2019 Jun 2;21(6):e10924. doi: 10.2196/10924.
8
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).干预措施以提高慢性阻塞性肺疾病(COPD)药物治疗的依从性。
Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD013381. doi: 10.1002/14651858.CD013381.pub2.
9
Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).中国稳定期 COPD 患者的恶化:一项前瞻性、52 周、全国性、观察性队列研究(REAL)的分析。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231167353. doi: 10.1177/17534666231167353.
10
Pain during exacerbation of chronic obstructive pulmonary disease: A prospective cohort study.慢性阻塞性肺疾病加重期的疼痛:一项前瞻性队列研究。
PLoS One. 2019 May 24;14(5):e0217370. doi: 10.1371/journal.pone.0217370. eCollection 2019.

本文引用的文献

1
Beyond breathing: Systematic review of global chronic obstructive pulmonary disease guidelines for pain management.呼吸之外:全球慢性阻塞性肺疾病疼痛管理指南的系统评价
Respir Med. 2024 Apr;224:107553. doi: 10.1016/j.rmed.2024.107553. Epub 2024 Feb 11.
2
Patients' acceptance of outcome and experience measurements during hospitalisation for COPD exacerbations: a CICERO Clinical Research Collaboration-European Lung Foundation online patient survey.慢性阻塞性肺疾病急性加重期住院患者对结局和体验测量的接受度:一项西塞罗临床研究协作组-欧洲肺脏基金会在线患者调查
ERJ Open Res. 2023 Jul 3;9(4). doi: 10.1183/23120541.00148-2023. eCollection 2023 Jul.
3
The prevalence and assessment of pain and dyspnoea in acute exacerbations of COPD: A systematic review.
COPD 急性加重期疼痛和呼吸困难的流行情况及评估:系统评价。
Chron Respir Dis. 2022 Jan-Dec;19:14799731221105518. doi: 10.1177/14799731221105518.
4
Charlson Comorbidity Index: A Critical Review of Clinimetric Properties.Charlson 共病指数:临床计量特性的批判性评价。
Psychother Psychosom. 2022;91(1):8-35. doi: 10.1159/000521288. Epub 2022 Jan 6.
5
A Systematic Review with Thematic Synthesis of the Experience of Hospitalization in People with Advanced Chronic Obstructive Pulmonary Disease.对患有晚期慢性阻塞性肺疾病的患者的住院体验进行系统评价和主题综合分析。
COPD. 2021 Oct;18(5):576-584. doi: 10.1080/15412555.2021.1971186. Epub 2021 Sep 3.
6
Association of dyspnoea, mortality and resource use in hospitalised patients.呼吸困难与住院患者死亡率及资源利用的相关性。
Eur Respir J. 2021 Sep 2;58(3). doi: 10.1183/13993003.02107-2019. Print 2021 Sep.
7
Clinical Consequences of COVID-19 Lockdown in Patients With COPD: Results of a Pre-Post Study in Spain.慢性阻塞性肺疾病患者因新冠疫情封锁措施产生的临床后果:西班牙一项前后对照研究的结果
Chest. 2021 Jul;160(1):135-138. doi: 10.1016/j.chest.2020.12.057. Epub 2021 Jan 11.
8
Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic.在 2019 冠状病毒病疫情期间,香港因慢性阻塞性肺疾病急性加重而住院的人数显著减少。
Respir Med. 2020 Sep;171:106085. doi: 10.1016/j.rmed.2020.106085. Epub 2020 Jul 12.
9
Physical exercise during acute exacerbations of chronic obstructive pulmonary disease: Australian physiotherapy practice.慢性阻塞性肺疾病急性加重期的体育锻炼:澳大利亚物理治疗实践
Chron Respir Dis. 2020 Jan-Dec;17:1479973120912821. doi: 10.1177/1479973120912821.
10
Use of pain scales and observational pain assessment tools in hospital settings.疼痛量表和观察性疼痛评估工具在医院环境中的应用。
Nurs Stand. 2019 Aug 29. doi: 10.7748/ns.2019.e11308.